Table 2.
Low Dose (15 mg/kg) | High Dose (30 mg/kg) | |||||||
---|---|---|---|---|---|---|---|---|
Inside the tumor border | Outside the tumor border | Inside the tumor border | Outside the tumor border | |||||
-Cancer | +Cancer | -Cancer | +Cancer | -Cancer | +Cancer | -Cancer | +Cancer | |
-Red FL | 1 | 6 | 21 | 1 | 0 | 5 | 20 | 2 |
+Red FL | 0 | 8 | 4 | 5 | 0 | 10 | 5 | 5 |
PPV % (95%CI) |
100.0% (63.1 – 100.0) |
55.6% (21.2 – 86.3) |
100.0% (73.5 – 100.0) |
50.0% (18.7 – 81.3) |
||||
NPV % (95%CI) |
N/A |
95.5% (77.2 – 99.9) |
N/A |
90.9% (70.8 – 98.9) |
||||
Sensitivity % (95%CI) |
57.1% (28.9 – 82.3) |
83.3% (35.9 – 99.6) |
66.7% (38.4 – 88.2) |
71.4% (29.0 – 96.3) |
||||
Specificity % (95%CI) |
100.0%a (2.5 – 100.0) |
84.0% (63.9 – 95.5) |
N/Ab |
80.0% (59.3 – 93.2) |
||||
DOR (95%CI) | N/A |
26.3 (2.38 – 288.94) |
N/A |
10 (1.5 – 67.6) |
FL fluorescence, PPV positive predictive value, NPV negative predictive value, CI confidence interval, DOR diagnostic odds ratio, N/A not applicable
aa single tumor negative biopsy was collected inside the demarcated tumor border
bno tumor negative biopsies collected inside the tumor border